Pharmacological approaches to improve endothelial repair mechanisms

作者: Christian Besler , Carola Doerries , Giovanna Giannotti , Thomas F Lüscher , Ulf Landmesser

DOI: 10.1586/14779072.6.8.1071

关键词:

摘要: Endothelial injury is thought to play a pivotal role in the development and progression of vascular diseases, such as atherosclerosis, hypertension or restenosis, well their complications, including myocardial infarction stroke. Accumulating evidence suggests that bone marrow-derived endothelial progenitor cells (EPCs) promote repair contribute ischemia-induced neovascularization. Coronary artery disease its risk factors, diabetes, hypercholesterolemia, smoking, are associated with reduced number impaired functional activity circulating EPCs. Moreover, initial data suggest EPC levels dysfunction an increased cardiovascular events, compatible concept EPC-mediated promotes disease. In this review we summarize recent on effects pharmacological agents mobilization particular, ...

参考文章(99)
Daniel P. Sieveking, Andrew Buckle, David S. Celermajer, Martin K.C. Ng, Strikingly Different Angiogenic Properties of Endothelial Progenitor Cell Subpopulations: Insights From a Novel Human Angiogenesis Assay Journal of the American College of Cardiology. ,vol. 51, pp. 660- 668 ,(2008) , 10.1016/J.JACC.2007.09.059
John E. Deanfield, Julian P. Halcox, Ton J. Rabelink, Endothelial Function and Dysfunction Testing and Clinical Relevance Circulation. ,vol. 115, pp. 1285- 1295 ,(2007) , 10.1161/CIRCULATIONAHA.106.652859
Alexandra Aicher, Markus Rentsch, Ken-ichiro Sasaki, Joachim W. Ellwart, Fred Fändrich, Reiner Siebert, John P. Cooke, Stefanie Dimmeler, Christopher Heeschen, Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia Circulation Research. ,vol. 100, pp. 581- 589 ,(2007) , 10.1161/01.RES.0000259562.63718.35
Atsuhiko Kawamoto, Heon-Cheol Gwon, Hideki Iwaguro, Jun-Ichi Yamaguchi, Shigeki Uchida, Haruchika Masuda, Marcy Silver, Hong Ma, Marianne Kearney, Jeffrey M. Isner, Takayuki Asahara, THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED ENDOTHELIAL PROGENITOR CELLS FOR MYOCARDIAL ISCHEMIA Circulation. ,vol. 103, pp. 634- 637 ,(2001) , 10.1161/01.CIR.103.5.634
Thomas Thum, Dimitrios Tsikas, Sylvia Stein, Maximilian Schultheiss, Martin Eigenthaler, Stefan D. Anker, Philip A. Poole-Wilson, Georg Ertl, Johann Bauersachs, Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. Journal of the American College of Cardiology. ,vol. 46, pp. 1693- 1701 ,(2005) , 10.1016/J.JACC.2005.04.066
Nikos Werner, Sonja Kosiol, Tobias Schiegl, Patrick Ahlers, Katrin Walenta, Andreas Link, Michael Böhm, Georg Nickenig, Circulating endothelial progenitor cells and cardiovascular outcomes. The New England Journal of Medicine. ,vol. 353, pp. 999- 1007 ,(2005) , 10.1056/NEJMOA043814
Sajoscha A. Sorrentino, Ferdinand H. Bahlmann, Christian Besler, Maja Müller, Svenja Schulz, Nina Kirchhoff, Carola Doerries, Tibor Horváth, Anne Limbourg, Florian Limbourg, Danilo Fliser, Hermann Haller, Helmut Drexler, Ulf Landmesser, Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation. ,vol. 116, pp. 163- 173 ,(2007) , 10.1161/CIRCULATIONAHA.106.684381
Giuseppe Patti, Vincenzo Pasceri, Rosetta Melfi, Costanza Goffredo, Massimo Chello, Andrea D’Ambrosio, Rosamaria Montesanti, Germano Di Sciascio, Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation Circulation. ,vol. 111, pp. 70- 75 ,(2005) , 10.1161/01.CIR.0000151308.06673.D2
Victor J. Dzau, Ruediger C. Braun-Dullaeus, Daniel G. Sedding, Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies Nature Medicine. ,vol. 8, pp. 1249- 1256 ,(2002) , 10.1038/NM1102-1249
Sonal Singh, Yoon K. Loke, Curt D. Furberg, Long-term Risk of Cardiovascular Events With Rosiglitazone JAMA. ,vol. 298, pp. 1189- 1195 ,(2007) , 10.1001/JAMA.298.10.1189